DEFIANCE TRILLION DC IDX ETF logo

DEFIANCE TRILLION DC IDX ETF Share Price (NASDAQ: TRIL)

$19.9

0.04

(0.2%)

Last updated on

Check the interactive DEFIANCE TRILLION DC IDX ETF Stock chart to analyse performance

DEFIANCE TRILLION DC IDX ETF Key Stats

Check DEFIANCE TRILLION DC IDX ETF key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$19.86
Market Capitalization
$1.9B
Revenue TTM
$43.0K
Earnings Per Share (EPS)
$-0.54
Dividend Yield
0.0%
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-21.67%

Stock Returns calculator for DEFIANCE TRILLION DC IDX ETF Stock including INR - Dollar returns

The DEFIANCE TRILLION DC IDX ETF stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

DEFIANCE TRILLION DC IDX ETF investment value today

Current value as on today

₹1,00,000

Returns

₹0

(0%)

Returns from DEFIANCE TRILLION DC IDX ETF Stock

₹0 (0%)

Dollar Returns*

₹0 (0%)

Indian investors sentiment towards DEFIANCE TRILLION DC IDX ETF Stock

0%

Period: Sep 18, 2025 to Oct 18, 2025. Change in 30 Days versus previous period

Search interest for DEFIANCE TRILLION DC IDX ETF Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on DEFIANCE TRILLION DC IDX ETF Stock

Rating
Trend

DEFIANCE TRILLION DC IDX ETF Share Price Target

What analysts predicted

Upside of 17.64%

Target:

$23.41

Current:

$19.90

DEFIANCE TRILLION DC IDX ETF share price target is $23.41, a slight Upside of 17.64% compared to current price of $19.90 as per analysts' prediction.

DEFIANCE TRILLION DC IDX ETF Stock Insights

  • Price Movement

    In the last 7 days, TRIL stock has moved up by 1.6%

DEFIANCE TRILLION DC IDX ETF Technicals Summary

Sell

Neutral

Buy

DEFIANCE TRILLION DC IDX ETF is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

DEFIANCE TRILLION DC IDX ETF Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
DEFIANCE TRILLION DC IDX ETF logo
-1.0%
-1.0%
-1.0%
-1.0%
46.14%
Beone Medicines Ltd logo
-5.38%
38.04%
43.88%
97.29%
5.51%
Alnylam Pharmaceuticals, Inc. logo
6.2%
106.95%
64.95%
149.6%
240.52%
Regeneron Pharmaceuticals, Inc. logo
-2.35%
2.95%
-40.31%
-18.11%
0.25%
Vertex Pharmaceuticals Incorporated logo
8.79%
-12.71%
-12.82%
43.65%
94.28%

About DEFIANCE TRILLION DC IDX ETF

As of November 17, 2021, Trillium Therapeutics Inc. was acquired by Pfizer Inc. Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. Its include TTI-622, a SIRPa-IgG4 Fc fusion protein that is designed to enhance macrophage-mediated phagocytosis and anti-tumor activity by blocking the CD47, which is in Phase 1 clinical trials; and TTI-621, a SIRPa-IgG1 Fc fusion protein, which is in Phase 1 clinical trials and generates a signal blocking the CD47 for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was incorporated in 2004 is based in Cambridge, Massachusetts.
Organization
DEFIANCE TRILLION DC IDX ETF
Employees
33
CEO
Dr. Jan Skvarka
Industry
Health Technology

Key Management of DEFIANCE TRILLION DC IDX ETF

NameTitle
Dr. Jan Skvarka
Pres, CEO & Director
Mr. James T. Parsons MAcc, CPA-CA
Chief Financial Officer
Dr. Robert Uger
Chief Scientific Officer
Dr. Penka Petrova
Chief Devel. Officer
Dr. Ingmar Bruns M.D., Ph.D.
Chief Medical Officer
Benjamin Looker
Gen. Counsel
Dr. Rosemary Harrison
Sr. VP of Corp. Devel. & Strategy
Dr. Michael G. Hill
Head of Calgary Site
Ms. Kathleen Large
Sr. VP - Clinical Operations

Important FAQs about investing in TRIL Stock from India :

What is DEFIANCE TRILLION DC IDX ETF share price today?

DEFIANCE TRILLION DC IDX ETF share price today is $19.90 as on at the close of the market. DEFIANCE TRILLION DC IDX ETF share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for DEFIANCE TRILLION DC IDX ETF share?

DEFIANCE TRILLION DC IDX ETF share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. DEFIANCE TRILLION DC IDX ETF stock price today i.e. is closed at $19.90, lower by 0% versus the 52 week high.

How to invest in DEFIANCE TRILLION DC IDX ETF Stock (TRIL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for DEFIANCE TRILLION DC IDX ETF on INDmoney app. Click on Buy button. You can invest as low as $1.5 in DEFIANCE TRILLION DC IDX ETF Shares that will get you 0.0754 shares as per DEFIANCE TRILLION DC IDX ETF share price of $19.90 per share as on October 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy DEFIANCE TRILLION DC IDX ETF Stock (TRIL) from India?

Indian investors can start investing in DEFIANCE TRILLION DC IDX ETF (TRIL) shares with as little as ₹87.9538 or $1 (as of October 19, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in DEFIANCE TRILLION DC IDX ETF stock (as per the Rupee-Dollar exchange rate as on October 19, 2025). Based on DEFIANCE TRILLION DC IDX ETF share’s latest price of $19.90 as on October 18, 2025 at 1:29 am IST, you will get 0.5025 shares of DEFIANCE TRILLION DC IDX ETF. Learn more about fractional shares .

What are the returns that DEFIANCE TRILLION DC IDX ETF has given to Indian investors in the last 5 years?

DEFIANCE TRILLION DC IDX ETF stock has given 46.14% share price returns and 19.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?